The trial will use the child’s own immune system for specifically targeting the Diffuse Intrinsic Pontine Glioma. Read more:...

A team of scientists has identified a new cell type implicated in the development of the most common type of malignant childhood brain...

Researchers at the University of Colorado Anschutz Medical Campus and partners become first to treat MYC amplified Medulloblastoma on a...

Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study...

Investigators have identified previously unknown sets of epigenetic changes in pediatric brain tumors, which could serve as novel ...

Results from a pooled case control study indicate that meninges are very radiosensitive in pediatric patients who were treated at prior ...

An enzyme that drives the growth of an often-lethal childhood brain cancer may hold the key to a future treatment, says a McMaster ...

Every year in the UK, around 55 children are diagnosed with medulloblastoma, and there is a pressing need for new treatments. Now, led...

Now, in a new proof-of-concept study published in the Journal for ImmunoTherapy of Cancer, researchers at Children's Hospital of...

While some pediatric brain cancers have known genetic causes, many do not. Three-dimensional profiling revealed new disease mechanisms...